| Type | MGI:General | Description | mice show attenuation of the development of nephropathy in streptozotocin (STZ)-induced diabetes, showing a delay in the development of albuminuria, renal protection with an early reduction in mesangial expansion and attenuation of glomerular hypertrophy at 16 weeks, less pronounced podocyte loss and reduction in cortical TGFB1 expression at 8 weeks |
